BIOCOM for BIOCOM
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Advocated for increased funding for NIH and FDA in FY2019 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Advocated for reforms of IPR proceedings at the PTAB, including support of the STRONGER Patents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Co-hosted a Life Science Reception Hosted a congressional briefing supporting the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) Discussed how the life science community can help address the opioid crisis Supported expanded coverage of whole-genome sequencing Advocated for enhancements of the 340B drug program Expressed concerns over the establishment of a private litigation mechanism in the CREATES Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Energy/Nuclear ENG
Supported mandatory funding for the Energy Title in the Farm Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Trade (domestic/foreign) TRD
Voiced opposition to tariffs on medical devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Advocated for the suspension of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.